Mineralys Therapeutics today announced the first patient dosed in the ADVANCE-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN...
Read moreOryzon Genomics announced today that its management will give an update on corporate progress at several international events on May-June
Read moreOryzon today announced the presentation of the trial in progress (TIP) FRIDA poster entitled Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myelo...
Read moreAt Expoquimia, Telstar promotes GMP digitization solutions and process automation for the pharma industry. Together with a new generation of equipment for formulation and R&D
Read moreThe study shows that more than 98% of the population would benefit from more effective treatments with fewer side effects if prescriptions were customised based on the patient’s genes, applying what...
Read moreA veces, la innovación farmacéutica se basa en una nueva forma de aplicación, con efectos más rápidos de actuación; en una mejora en la composición, que reduce los efectos adversos, o en un nue...
Read more3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its internatio...
Read moreTelstar’s innovative station is fitted with several robots to assess the handling of stackable trays according to the type of product such as bags or bottles
Read moreHan presentado los resultados del estudio clínico Farmagonacol sobre la eficacia de un producto nutricéutico que consigue reducir un 9% el colesterol total y un 12% lo del tipo LDL en personas con h...
Read moreThe project has integrated data from more than 10,000 pharmacological studies by reference pharmaceutical companies, from a dozen databases that amass public and private information of clinical and pr...
Read moreEl Instituto de Biología Integrativa de Sistemas (I2SysBio, CSIC-UV) detecta en nudibranquios una bacteria simbiótica con genes para producir moléculas con aplicacionfarmacológicas
Read moreOryzon Genomics today reports new preliminary blinded aggregate safety data from its ongoing Phase IIb PORTICO trial, investigating vafidemstat in Borderline Personality Disorder (BDP).
Read more